Outlook on the Electrical Stimulation Devices Global Market to 2027 - Featuring Abbott Laboratories, Boston Scientific & BTL Industries Among Others - ResearchAndMarkets.com

The "Electrical Stimulation Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Monday, June 28, 2021
Information
Tags: 
Medical devices, Health, Branches of biology, Neuroscience, Neurotechnology, Electrotherapy, Neuroprosthetics, Surgery, Vagus nerve stimulation, VNS, Vagus nerve, Neuromodulation
Geotags: 
JAPAN, US, EUROPE, CHINA, INDIA, SOUTH KOREA, USA, AUSTRALIA, CANADA, GERMANY
⚠generated by AI ↴
Summary
Key Points: 
  • The "Electrical Stimulation Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 4.3% CAGR
    The Electrical Stimulation Devices market in the U.S. is estimated at US$1.5 Billion in the year 2020.
  • In the global Vagus Nerve Stimulation (VNS) Devices segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$790.7 Million by the year 2027.


The "Electrical Stimulation Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Electrical Stimulation Devices estimated at US$5 Billion in the year 2020, is projected to reach a revised size of US$6.9 Billion by 2027, growing at a CAGR of 4.6% over the analysis period 2020-2027.

Spinal Cord Stimulation (SCS) Devices, one of the segments analyzed in the report, is projected to record a 5.4% CAGR and reach US$3.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Deep Brain Stimulation (DBS) Devices segment is readjusted to a revised 4.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 4.3% CAGR

The Electrical Stimulation Devices market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2027 trailing a CAGR of 4.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Vagus Nerve Stimulation (VNS) Devices Segment to Record 3.9% CAGR

In the global Vagus Nerve Stimulation (VNS) Devices segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$383.2 Million in the year 2020 will reach a projected size of US$501.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$790.7 Million by the year 2027.

Select Competitors (Total 31 Featured):

  • Abbott Laboratories
  • Boston Scientific Corporation
  • BTL Industries, Inc.
  • Cogentix Medical, Inc.
  • Cyberonics, Inc.
  • DJO Global, Inc.
  • Medtronic PLC
  • NeuroMetrix, Inc.
  • Nevro Corp.
  • Zynex Medical

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • Influencer Market Insights
  • Impact of Covid-19 and a Looming Global Recession

III. MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 31

For more information about this report visit https://www.researchandmarkets.com/r/vq1sd1

Copyright: 
Copyright Business Wire 2021